Frontiers in Tuberculosis
Frontiers Media S.A. · Switzerland
Aims & Scope✦ Inferred from recent articles
This journal focuses on tuberculosis (TB) and non-tuberculous mycobacterial (NTM) diseases. Research covers diagnostics, treatment strategies, prevention, and understanding host-pathogen interactions. It also addresses implementation science, health system readiness, and patient-centered interventions, particularly in high-burden settings. The scope includes molecular mechanisms, immune responses, and epidemiological studies related to these infections.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about Frontiers in Tuberculosis
Is Frontiers in Tuberculosis a predatory journal?
PubScope has no integrity flags on record for Frontiers in Tuberculosis: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 58/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Frontiers in Tuberculosis?
Frontiers in Tuberculosis is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is Frontiers in Tuberculosis indexed in Scopus and Web of Science?
Frontiers in Tuberculosis is indexed in DOAJ.
How much does it cost to publish in Frontiers in Tuberculosis?
Frontiers in Tuberculosis charges an article processing charge (APC) of about CHF 1,950 for open-access publication.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref